Podcasts

Navigating through the complexities of the CLL treatment landscape

Dr. Othman Al-Sawaf (University Hospital Cologne, Germany)

Dr Othman Al-Sawaf is a Hematologist and Medical Oncologist at the University Hospital Cologne, Cologne, Germany, and serves as a study physician at the German CLL Study Group (GCLLSG). He has a strong interest in the principles of cancer evolution and cancer metabolism in diseases such as chronic lymphocytic leukemia (CLL).  In his research, he investigates computational approaches for the discovery and development of new treatment strategies in clinical oncology. He works as a coordinating physician and principal investigator for both national and international Phase I to III clinical trials.

This HematoTalk is brought to you by the publisher of the Belgian Journal of Hematology (BJH) in partnership with AstraZeneca.

NS ID BE-3956-Revision date 09/2025-WEB Local code 1662

SUBSCRIBE TO BJH HEMATALKS SERIES